Pacer Advisors
CLBT icon

Pacer Advisors’s Cellebrite CLBT Stock Holding History

Pacer Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Buy
8,702
+1,095
+14% +$14.5K ﹤0.01% 1861
2026
Q1 		$105K Buy
7,607
+3,626
+91% +$54.6K ﹤0.01% 1842
2025
Q4 		$71.8K Buy
3,981
+1,238
+45% +$22.2K ﹤0.01% 3182
2025
Q3 		$50.8K Buy
2,743
+2,303
+523% +$36.2K ﹤0.01% 3038
2025
Q2 		$7.04K Buy
+440
New +$7.84K ﹤0.01% 3242

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Pacer Advisors's CLBT Position: Q2 2026 in Review

Pacer Advisors increased its Cellebrite (CLBT) stake by 14% in Q2 2026, buying an estimated $14.5K and bringing the position to 8,702 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #1861.

Pacer Advisors first reported a position in CLBT in Q2 2025 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Pacer Advisors held 8,702 shares of Cellebrite worth $127K as of Q2 2026.
  • Pacer Advisors bought 1,095 Cellebrite shares in Q2 2026, an estimated $14.5K.
  • Cellebrite made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1861 holding.
  • Pacer Advisors first reported a position in Cellebrite in Q2 2025 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.